Samsung Epis Holdings Co., Ltd. (KOSE: A0126Z0)
Health Care · Biotechnology · KR
₩433,500.00
+2.73% today · -1.1% 1Y
Samsung Epis Holdings Co., Ltd. (KOSE: A0126Z0) operates in the Biotechnology industry within the Health Care sector. The company is valued at $7.62B.
Over the last twelve months the share price has lost 1.1%, trading between 329.00K and 773.00K.
A0126Z0 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.62B
- Revenue (TTM)
- $1.05B
- P/E
- 21.05
- EPS
- 20,595.17
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩773,000.00
- 52-week low
- ₩329,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 24.84M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $263.50 | -0.55% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $440.25 | +0.21% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $145.32 | -0.55% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.33 | +0.05% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $825.06 | -1.08% |
| argenx SEENXTBR: ARGX | $65.85B | €867.40 | -3.84% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $135.44 | -6.64% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.